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Quality of life in patients with
intermittent claudication
Introduction
Peripheral arterial disease (PAD) is
a common chronic condition that can
cause lower extremity pain when walk-
ing; classically known as intermittent
claudication (IC). Clinically patients
have diminished or absent pulse on
physical examination and an ankle-
brachial pressure index (ABPI) of <0.9
[28]. The prevalence of PAD is around
4% increasing with age, gender, ethnicity
and rises up to and above 10% over the
age of 70 years [27].
The impact of PAD on quality of life
has been well demonstrated [31], with
IC not only aﬀecting walking distance,
capacity and physical activity but social
function, emotionalwell-being andmen-
tal health [35]. The primary treatment
aimis thereforenotonly to improveblood
ﬂow into the leg but also the quality of life
for the patient. National governing bod-
ies recommendasupervisedexercisepro-
gramme as the ﬁrst line treatment, along
with best medical therapy [25]. If super-
vised exercise is not feasible, acceptable
or accessible for patients [17] then more
invasive therapies, such as angioplasty or
bypasssurgerymaybeutilised. Qualityof
life (QoL) is an important outcomemea-
sure with theWorldHealth Organization
(WHO)deﬁningitas“physical, socialand
mentalwell-beingandnot just anabsence
of inﬁrmity” [31]. Since QoL is an im-
portant outcome indicator of treatment
success, most clinical trials include some
form of QoL measure amongst their out-
comes. The QoL can be measured with
either generic or disease-speciﬁc ques-
tionnaires and although there are a mul-
titude of questionnaires available for use
in the PAD population, no consensus
exists as to which questionnaire is the
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Table 1 Summary of the study characteristics including all values for PADpatients (ABPI is taken at rest in theworst aﬀected limb an data are
presented asmean±SD)
Author, year Sample size
(n)
Age (years) Males (%) ABPI Intervention QoL used
1 Shuriquie et al. [37] 96 59 ± 15.6 65
(67.7)
Not reported Bypass surgery AUSVIQOL –
Arabic
2 Haitjema et al. [16] 865 68 623
(72.0)
0.59 ± 0.21 Endarterectomy SF36
3 Prévost et al. [36] 46 60.3 ± 8 40
(87.0)
0.7 ± 0.1 Home exercise pro-
gramme
SF36 – French
4 Maksimovic et al.
[28]
102 68.9 ± 8 33
(32.4)
Not reported None SF36 – Serbian
5 Inglis et al. [21] 173 60.5 ± 15.4 70
(40.5)
Not reported None SF12
6 Guidon and McGee
2013 [14]
44 67 ± 8 33
(75.0)
0.77 ± 0.21 Supervised exercise WIQ
SF36
ICQ
7 Fritschi et al. [12] 105 68.9 ± 8.35 64
(61.0)
Not reported None SF36
WIQ
8 Frans et al. [11] 40 67 25
(62.5)
0.67 ± 0.21 None SF36
VascuQoL
ALDS
9 Lee et al. [26] 63 55 ± 12 15
(23.8)
Not reported None PAQ
10 Fakhry et al. [10] 217 67.5 ± 9.5 135
(62.2)
0.62 ± 0.19 Home exercise pro-
gramme vs. supervised
exercise programme
SF36
EuroQoL
VascuQoL
11 Malagoni et al. [29] 250 70.5 ± 9.2 191
(76.4)
Not reported Home exercise pro-
gramme
SF36
12 Yan et al. [42] 134 71 ± 9 94
(70.1)
0.6 ± 0.2 None WIQ
13 Hedeager Momsen
et al. [19]
88 67.4 ± 6.9 56
(63.6)
0.53 Revascularisation SF36
WIQ
14 Leicht et al. [27] 28 69 ± 7.6 22
(78.6)
0.7 ± 0.1 None ICQ
SF36
15 Tsai et al. [39] 53 76.2 ± 3.7 44
(83.0)
0.7 ± 0.1 Supervised exercise pro-
gramme
SF36 – Chinese
16 Breek et al. [6] 151 63 100
(66.2)
Not reported None WHOQoL-100
17 Bosch and Hunink
[4]
254 58 183
(72.0)
Not reported None RAND-36
HUI3
EQ5D
18 Hicken et al. [20] 96 68 64
(66.7)
>0.9 None EQ5D
19 Mangiaﬁco et al.
[30]
42 64 ± 8 37
(88.1)
0.55 ± 0.22 Drug intervention
(prostaglandin)
WIQ
RAND-36
20 Bartman et al. [2] 44 70.5 ± 6 43
(97.7)
<0.9 None SF36
HUI3
Rating scale
21 Cook and Galland [9] 24 66 12
(50.0)
Not reported Revascularisation EuroQoL
Walking distance
score
Visual analog
scale
22 Je et al. [22] 149 70.3 ± 9.7 125
(83.9)
0.75 ± 0.24 Revascularisation PAQ
23 Oka and Sanders
[34]
74 72 ± 7 56
(75.7)
0.67 ± 0.14 None SF36
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most appropriate in this group. To date,
there has been no systematic review of
QoL assessment methods and outcomes
in clinical trials involving claudicants or
following interventional procedures for
PAD. The following review aims to cor-
rect this deﬁcit in the literature.
Methods
Search strategy
A systematic review of randomised clin-
ical trials including a primary analysis of
QoL via questionnaire was performed.
The Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses
(PRISMA) guidelines was used for re-
porting search results.
Inclusion criteria
Trials involving patients with diagnosed
PAD were included (either clinically or
by questionnaire). Any study involving
patients with critical limb ischemia or
self-reported PAD status was excluded.
Any trial which had QoL as the primary
outcome data was included with no limit
being placed on the type of questionnaire
used.
Database search
This systematic search of the MEDLINE,
CENTRAL and Embase databases was
performed. The search strategy aimed to
include any trial where QoL was spec-
iﬁed as the primary outcome measure.
Search terms used were: “intermittent
claudication” [OR] “peripheral arterial
disease” [AND] “QUALITY OF LIFE”
[OR] “SF36” [OR] “QUESTIONNAIRE”
[OR] “EQ5D” [OR] “VASCUQOL”.
Searches were limited to run from
1947 to September 2016, full text ar-
ticles related to adults over the age of
18 years and published in the English
language. Abstracts were independently
assessed for relevance by two reviewers
(A. H& J. T). Citations from the full texts
of relevant reports were hand searched
for other relevant references.
Abstract · Zusammenfassung
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Abstract
Background. Intermittent claudication (IC)
is a common condition that causes pain in
the lower limbs when walking and has been
shown to severely impact the quality of life
(QoL) of patients. The QoL is therefore often
regarded as an important measure in clinical
trials investigating intermittent claudication.
To date, no consensus exits on the type of life
questionnaire to be used. This review aims
to examine the QoL questionnaires used in
trials investigating peripheral arterial disease
(PAD).
Material andmethods. A systematic review
of randomised clinical trials including
a primary analysis of QoL via questionnaire
was performed. Trials involving patients
with diagnosed PAD were included (either
clinically or by questionnaire). Any trial which
had QoL as the primary outcome data was
included with no limit being placed on the
type of questionnaire used.
Results. The search yielded a total of 1845
articles of which 31 were deemed appropriate
for inclusion in the review. In total, 14
diﬀerent QoL questionnaireswere used across
31 studies. Of the questionnaires 24.06%were
missing at least one domain when reported
in the results of the study. Mean standard
deviation varied widely based on the domain
reported, particularly within the SF36.
Discussion. Despite previous recommen-
dations for Europewide standardisation
of quality of life assessment, to date no
such tool exists. This review demonstrated
that a number of diﬀerent questionnaires
remain in use, that their completion is often
inadequate and that further evidence-based
guidelines on QoL assessment are required to
guide future research.
Keywords
Ankle brachial index · Exercise · Peripheral
arterial disease · Questionnaire · Review
Lebensqualität bei Patientenmit Claudicatio intermittens
Zusammenfassung
Hintergrund. Die Claudicatio intermittens
(CI) ist eine häuﬁge Erkrankung, die beim
Gehen Schmerzen in der unteren Extremität
verursacht und die Lebensqualität (QoL) der
Patienten nachweislich beeinträchtigt. Daher
wird die QoL oft als wichtigesMessinstrument
in klinischen Studien angesehen, welche
die Claudicatio intermittens untersuchen.
Bis heute gibt es keinen Konsens bezüglich
der Art des zu verwendenden Lebensqua-
litätsfragebogens. Ziel dieses Reviews ist
es, die Fragebögen zur Lebensqualität zu
untersuchen, die in Studien zur peripheren
arteriellen Verschlusskrankheit (PAVK) zum
Einsatz kommen.
Material und Methoden. Ein systematischer
Review von randomisierten klinischen Stu-
dien einschließlich einer QoL-Primäranalyse
mittels Fragebogen wurde durchgeführt.
Studien an Patienten mit diagnostizierter
PAVK wurden eingeschlossen (entweder
klinisch oder mittels Fragebogen). Jede
Studie, die QoL als primären Endpunkt hatte,
wurde eingeschlossen, ohne Limitierung
hinsichtlich der Art des verwendeten
Fragebogens.
Ergebnisse. Die Suche ergab insgesamt 1845
Artikel, von denen 31 für den Einschluss in
die Studie als geeignet befunden wurden.
Insgesamt 14 verschiedene QoL-Fragebögen
kamen in den 31 Studien zum Einsatz. Bei
24,06% der Fragebögen fehlte mindestens
eine Domäne in den berichteten Studiener-
gebnissen. Die mittlere Standardabweichung
ﬁel, je nach berichteter Domäne, sehr
unterschiedlich aus, insbesondere im SF36.
Diskussion. Trotz früherer Empfehlungen
für eine europaweite Standardisierung der
Beurteilung der Lebensqualität, existiert hier-
für bis heute kein Instrument. Dieser Review
zeigte, dass weiterhin etliche verschiedene
Fragebögen verwendet werden, dass deren
Vollständigkeit häuﬁg inadäquat ist und
dass weitere evidenzbasierte Leitlinien zur
Beurteilung der Lebensqualität notwendig
sind, um für die zukünftige Forschung
wegweisend zu sein.
Schlüsselwörter
Knöchel-Arm-Index · Bewegung · Periphere
arterielle Verschlusskrankheit · Fragebogen ·
Review
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Table 1 Summary of the study characteristics including all values for PADpatients (ABPI is taken at rest in theworst aﬀected limb an data are
presented asmean±SD) (Continued)
Author, year Sample size
(n)
Age (years) Males (%) ABPI Intervention QoL used
24 Gardner et al. [13] 201 67 ± 9 159
(79.1)
0.7 ± 0.22 None SF36
WIQ
25 Kalbaugh et al. [23] 54 64.5 ± 11.2 Not reported Not reported Revascularisation SF36
26 Nicolai et al. [33] 91 66.2 ± 9.6 56
(61.5)
0.72 ± 0.17 Supervised exercise pro-
gramme
WIQ
RAND-36
EuroQoL
27 Keeling et al. [24] 40 63 25
(62.5)
Not reported Revascularisation SF36
28 Virkkunen et al. [40] 27 69.3 ± 10.7 Not reported 0.63 Revascularisation NHP
29 Aquarius et al. [1] 188 64.7 ± 9.9 119
(63.3)
0.61 None RAND-36
WHOQoL-100
30 Breek et al. [5] 200 63 135
(67.5)
0.62 None RAND-36
WHOQoL-100
31 Spertus et al. [38] 44 68 ± 11 24
(54.5)
Not reported None PAQ
WIQ
SF36
ABPI ankle-brachial pressure index
Data extraction
Data were extracted from full text arti-
cles by two investigators (A. H & J. T)
using a standardised data extraction ex-
cel spreadsheet. Any disagreement as to
inclusion of an article between the two
assessing investigatorswassettledbycon-
sensus with a third investigator (G. S).
Results
Search results
As summarised in . Fig. 1, the search
yielded a total of 1845 articles of which
31weredeemedappropriate for inclusion
in the review (. Table 1).
A range of interventions (including
revascularisation, drug intervention and
exercise therapy) were used in included
papers alongside a variety of QoL data.
The QoL data collection varied widely in
both the timing of collection and the tool
or questionnaire utilised. Study charac-
teristics including sample size, age and
ankle-brachial pressure indices (ABPI)
and QoL data collection tools utilised
are summarised in . Table 1.
Number of questionnaires used
A wide variety of QoL measuring tools
were used in the studies included in the
review. The most commonly used tool
was the Short Form 36 (SF-36) or varia-
tions of it, used in 23 out of the 31 studies
included (74.19%)with a total of 3256pa-
tients and 12 studies used the SF-36 in its
English form [2, 10–14, 19, 20, 23, 24, 34,
38]. Translatedversionsof theSF-36were
used in Serbian [28], Dutch [16], French
[36], Italian [29]andChinese [39]. Of the
23 studies 5 utilised the RAND-36 tool
[1, 4, 5, 30, 33], which contains the same
question set as the SF-36 but is analysed
diﬀerently [18]. The second most com-
monquestionnaire usedwas theWalking
Impairment Questionnaire (WIQ) used
in 8 out of 31 studies (total 749 patients)
[12–14, 19, 30, 33, 38, 42], including a di-
rect comparison by Nicolai et al. of the
WIQ and the SF-36. This is followed by
the EuroQol questionnaire, or EQ–5D,
used in 4 studies (586 patients) [4, 9, 10,
33].
In each of three studies two question-
naires were used; the Peripheral Artery
Disease Quality of Life (PADQOL) tool
[22, 26, 38] and the World Health Orga-
nization Quality of Life (WHOQoL-100)
[1, 5, 6]. Other studies used included the
Australian VascularQuality of Life Index
(AUSVIQOL) [37], the Vascular Quality
of Life questionnaire (VASCUQOL) [10,
11], the Intermittent Claudication Ques-
tionnaire (ICQ) [14, 27], theNottingham
Health Proﬁle (NHP) [40], the Health
Utilities Index (HUI) questionnaire [2,
4] and Visual Analog Scales [9]. In total,
14 diﬀerent QoL assessment tools were
used across the 31 studies, with a total
of 3928 patients surveyed.
Number of incomplete domains
A number of studies did not fully re-
port QoL assessment data, with several
omitting domains in their ﬁnal publi-
cation. Of the 23 studies using SF-36
or a variant, 6 (26.09%) reported the
results of 10 domains [11, 12, 14, 23,
34, 38], including a Physical Component
Summary (PCS) andMental Component
Summary (MCS). The median reported
domain in the SF-36 group was 8 (range
2–10). Apart from the PCS andMCS, the
most commonly omitted domain of the
SF-36 was Mental Health [10, 30]. Only
1 out of 8 (12.5%) [42] studies utilising
the WIQ reported pain as an outcome.
Stability [30] and Activity [13] were re-
ported in 1 out of 8 WIQ studies each,
with the remaining5 studies reportingon
only 3 domains of the WIQ (62.5%) and
1 out of 3 studies using PADQOL did not
report all domains, Spertus et al. [38],
omitting physical function. Only 1 out of
3 studies utilising the WHOQoL-100 re-
ported all domains, with Breek et al. [5]
omitting a single domain and Aquarius
et al. [1] omitting 8. Of the 31 studies in
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this review, 24.06% of all questionnaires
were missing at least 1 domain when re-
ported in the results of the study.
Variance of individual results
A common theme of the extracted QoL
data is individual variance of the results.
A large majority (86.79%) of results were
reported as mean ± standard deviation.
WithineachQoLquestionnaire somedo-
mains have very large standard devia-
tions, suggesting the spread of individual
results is wide and therefore less reliable.
In the two papers using ICQ (measured
on a 0–100 scale [8]), mean standard de-
viation was 17.57. In studies using SF-
36 or RAND-36 (that also have a total
available score of 100 [41]), mean stan-
dard deviation ranged from 14.67 in the
Mental Health domain to 29.41 in Role
Limitation (Emotional), suggesting that
some domains are more reliably inter-
preted than others.
Discussion
Number of questionnaires used
and quality of study completion
Despite a recommendation for Europe-
wide standardisation of QoL assessment
in 1997 [7] and again in 2009 [15], this
review found that a wide variety of as-
sessment tools remain in use. These tools
diﬀer in the domains that they measure,
and although there is crossover of do-
mains in some tools [3, 4, 32], the use of
lesser known QoL utilities may lead to
diﬃculty in interpretationof anyﬁndings
and comparisons between interventions.
This review showed that in those tri-
als where a multidomain QoL utility was
used (such as the SF-36, WIQ or WHO-
QoL-100), it was common for domains
to be omitted in the ﬁnal report, often
without explanation. We also found that
a number of diﬀerent QoL assessment
tools are in use in patients with PAD,
and that these are often incompletely re-
ported. Further, up to date research is
needed to identify the most appropri-
ate standard for QoL measurement that
is both thorough and related to clini-
cal outcome and acceptable for patients
in terms of their ability to understand
the questionnaire and the time taken to
complete it.
Limitations
This review focussed on articles where
data was presented numerically for indi-
vidual QoL assessment tools, and there-
fore could be extracted from the study
for further analysis. This accounts some-
what for the high number of exclusions
between full text screening (120), and the
ﬁnal number of papers (31) included in
the review (full reasons for exclusion are
shown in . Fig. 1). A total of 13 studies
presented their data in graphical format
only, or had no data present to extract,
15 studies presentedonlydata comparing
twodiﬀerentQoLutilities, themajorityof
these presenting correlation coeﬃcients
and 9 articles did not present results as
mean values, instead presenting median,
mode, range or quintiles.
Practical conclusion
Whilst QoL is regarded as an important
clinical outcomemeasure for use in
patients with PAD, this review found
that standardisation of reporting QoL
outcomes was poor, suggesting that
a consensus on reporting standards
relating to QoLmeasures is needed
in order to guide future study design
and allowmore accurate comparisons
between interventions.
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In eigener Sache
Die beliebtesten CME-Beiträge
2016
Hier präsentieren wir Ihnen die zwei
von unseren Lesern am besten be-
werteten CME-Beiträge aus Gefäss-
chirurgie 2016. Jedem Teilnehmer
wird nach der Bearbeitung eines Bei-
trags der Rubrik „CME – Zertifizier-
te Fortbildung“ auf Springermedi-
zin.de die Möglichkeit geboten, die-
sen zu bewerten. Dabei erzielten die
untenstehenden Beiträge Höchstno-
ten. ImNamender Schriftleitung und
der Herausgeber vonGefässchirurgie
bedanken wir, die Redaktion, uns bei
den Autoren für das außerordentli-
che Engagement beim Verfassen der
Beiträge.
Rekanalisierende Therapie der tiefen
Bein-/Beckenvenenthrombose
aus: Gefässchirurgie 1/2016
von: A. Mumme, T. Hummel
Zertiﬁziert bis: 16.02.2017
Popliteales Entrapment-Syndrom
aus: Gefässchirurgie 5/2016
von: M. Wortmann, A. S. Peters, D. Böckler
Zertiﬁziert bis: 05.09.2017
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